XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statement of Changes in Redeemable Noncontrolling Interests and Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Redeemable Noncontrolling Interest
Outstanding shares, beginning balance (in shares) at Jul. 31, 2022     952,163,896        
Stockholders' equity, beginning balance at Jul. 31, 2022 $ 4,625,599   $ 96 $ 838,460 $ (169,365) $ 3,956,408  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 245,848         245,848  
Currency translation adjustment (29,571)       (29,571)    
Exercise of stock options, net of repurchased shares (in shares)     151,108        
Exercise of stock options, net of repurchased shares 766     1,061   (295)  
Stock-based compensation (in shares)     76,624        
Stock-based compensation 10,192     10,192      
Outstanding shares, ending balance (in shares) at Oct. 31, 2022     952,391,628        
Stockholders' equity, ending balance at Oct. 31, 2022 4,852,834   $ 96 849,713 (198,936) 4,201,961  
Outstanding shares, beginning balance (in shares) at Jul. 31, 2022     952,163,896        
Stockholders' equity, beginning balance at Jul. 31, 2022 4,625,599   $ 96 838,460 (169,365) 3,956,408  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 539,525            
Currency translation adjustment 12,858            
Outstanding shares, ending balance (in shares) at Jan. 31, 2023     953,128,296        
Stockholders' equity, ending balance at Jan. 31, 2023 5,213,652   $ 96 874,961 (156,507) 4,495,102  
Outstanding shares, beginning balance (in shares) at Oct. 31, 2022     952,391,628        
Stockholders' equity, beginning balance at Oct. 31, 2022 4,852,834   $ 96 849,713 (198,936) 4,201,961  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 293,677         293,677  
Currency translation adjustment 42,429       42,429    
Exercise of stock options, net of repurchased shares (in shares)     446,852        
Exercise of stock options, net of repurchased shares 9,218     9,754   (536)  
Stock-based compensation (in shares)     60,702        
Stock-based compensation 10,131     10,131      
Shares issued for Employee Stock Purchase Plan (in shares)     229,114        
Shares issued for Employee Stock Purchase Plan 5,363     5,363      
Outstanding shares, ending balance (in shares) at Jan. 31, 2023     953,128,296        
Stockholders' equity, ending balance at Jan. 31, 2023 $ 5,213,652   $ 96 874,961 (156,507) 4,495,102  
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023 957,344,162   957,344,162        
Stockholders' equity, beginning balance at Jul. 31, 2023 $ 5,987,440 $ 5,987,440 $ 96 938,910 (141,006) 5,189,440 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss)   332,527       332,527 5
Currency translation adjustment   (36,353)     (36,353)    
Acquisition of noncontrolling interest (in shares)     2,499,993        
Acquisition of noncontrolling interest   112,075   112,075     25,217
Exercise of stock options, net of repurchased shares (in shares)     331,358        
Exercise of stock options, net of repurchased shares   7,412   8,123   (711)  
Stock-based compensation (in shares)     32,761        
Stock-based compensation   8,316   8,316      
Outstanding shares, ending balance (in shares) at Oct. 31, 2023     960,208,274        
Stockholders' equity, ending balance at Oct. 31, 2023   6,411,417 $ 96 1,067,424 (177,359) 5,521,256 25,222
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023 957,344,162   957,344,162        
Stockholders' equity, beginning balance at Jul. 31, 2023 $ 5,987,440 5,987,440 $ 96 938,910 (141,006) 5,189,440 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 658,059            
Currency translation adjustment $ (4,273)            
Exercise of stock options, net of repurchased shares (in shares) 1,160,000            
Outstanding shares, ending balance (in shares) at Jan. 31, 2024 961,311,496   961,311,496        
Stockholders' equity, ending balance at Jan. 31, 2024 $ 6,787,600 6,787,600 $ 96 1,087,345 (145,279) 5,845,438 25,114
Outstanding shares, beginning balance (in shares) at Oct. 31, 2023     960,208,274        
Stockholders' equity, beginning balance at Oct. 31, 2023   6,411,417 $ 96 1,067,424 (177,359) 5,521,256 25,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 325,527 325,635       325,635 (108)
Currency translation adjustment $ 32,080 32,080     32,080    
Exercise of stock options, net of repurchased shares (in shares)     828,799        
Exercise of stock options, net of repurchased shares   3,906   5,359   (1,453)  
Stock-based compensation (in shares)     119,004        
Stock-based compensation   8,601   8,601      
Shares issued for Employee Stock Purchase Plan (in shares)     155,419        
Shares issued for Employee Stock Purchase Plan   5,961   5,961      
Outstanding shares, ending balance (in shares) at Jan. 31, 2024 961,311,496   961,311,496        
Stockholders' equity, ending balance at Jan. 31, 2024 $ 6,787,600 $ 6,787,600 $ 96 $ 1,087,345 $ (145,279) $ 5,845,438 $ 25,114